80061

Lipid panel

CPT code 80061 represents a lipid panel, which is a specialized diagnostic blood test that measures lipids—fats and fatty substances used as a source of energy by the body. This comprehensive panel is specifically designed to evaluate a patient's risk of developing cardiovascular disease, monitor the progression of known lipid disorders, and assess the clinical effectiveness of prescribed lipid-lowering therapies. A standard lipid panel mandates the inclusion of three specific laboratory tests: total serum cholesterol (82465), direct measurement of high-density lipoprotein (HDL) cholesterol (83718), and triglycerides (84478). Low-density lipoprotein (LDL) is most often calculated from these constituent values using the Friedewald equation or similar mathematical formulas, although a direct laboratory measurement of LDL is billed under a distinct CPT code if explicitly ordered and performed. Total cholesterol measures the sum of all cholesterol content circulating in the blood. HDL cholesterol, frequently referred to in clinical practice as 'good' cholesterol, is primarily responsible for transporting cholesterol away from the arterial walls and back to the liver, where it is subsequently processed and eliminated from the body. High circulating levels of HDL are generally associated with a reduced risk of atherosclerotic cardiovascular disease. Conversely, triglycerides are a distinct type of fat found in the blood; elevated triglyceride levels, particularly when compounded with high levels of low-density lipoprotein (LDL) or abnormally low HDL, can significantly amplify the risk of developing atherosclerosis, myocardial infarctions, and cerebrovascular accidents. Clinically, this panel is paramount in the routine screening of adult patients to assess their 10-year risk of developing atherosclerotic cardiovascular disease (ASCVD). It is heavily utilized across primary care, cardiology, and endocrinology practices. Proper patient preparation historically requires a strict fasting state of 9 to 12 hours prior to the blood draw to ensure highly accurate triglyceride measurements, although non-fasting lipid panels are becoming increasingly accepted for initial, general screening purposes depending on specific clinical organizational guidelines. Blood is drawn via standard venipuncture, usually from the antecubital vein, collected in a specific additive tube (typically a serum separator tube or lithium heparin plasma tube), and centrifuged before the serum or plasma is analyzed utilizing automated clinical chemistry analyzers. When reporting CPT code 80061, the testing laboratory must have performed all three constituent tests. If only one or two of the components are tested, the individual CPT codes for those specific laboratory tests must be utilized instead of the comprehensive panel code.

Clinical Indications

  • Routine screening for cardiovascular disease risk assessment in adult patients and at-risk pediatric populations.
  • Monitoring patients with a known and established diagnosis of hyperlipidemia, hypercholesterolemia, or hypertriglyceridemia.
  • Evaluating the clinical efficacy of prescribed lipid-lowering medications, such as statins, fibrates, or PCSK9 inhibitors.
  • Assessing baseline and ongoing cardiovascular risk in patients diagnosed with metabolic syndrome, diabetes mellitus, or chronic hypertension.
  • Investigating the underlying etiology of clinical conditions potentially related to severe dyslipidemia, such as acute pancreatitis or the presence of xanthelasma.
  • Establishing a baseline metabolic assessment prior to initiating pharmacotherapy known to adversely affect lipid profiles, such as certain antiretroviral medications, immunosuppressants, or atypical antipsychotics.

Procedure Steps

  1. Patient Preparation: Verify patient identity using two identifiers and confirm whether the patient has maintained a fasting state for the required duration (typically 9-12 hours), if a fasting lipid panel is specifically ordered by the physician.
  2. Site Selection and Preparation: Select an appropriate peripheral vein, typically the median cubital vein located in the antecubital fossa. Apply a tourniquet proximal to the site and cleanse the area with a 70% isopropyl alcohol swab using friction.
  3. Venipuncture: Insert a sterile, single-use needle into the selected vein and collect the whole blood sample into the appropriate collection tube (e.g., serum separator tube or plasma tube containing lithium heparin).
  4. Sample Handling: Invert the collection tube gently multiple times immediately after collection to ensure adequate mixing of the blood with the tube's additive or clotting activator. Remove the tourniquet, swiftly withdraw the needle, and apply sustained pressure and an adhesive bandage to the puncture site.
  5. Centrifugation: Transport the securely labeled specimen to the laboratory processing area and centrifuge it at the appropriate speed and duration to properly separate the serum or plasma from the cellular components of the whole blood.
  6. Laboratory Analysis: Process the isolated serum or plasma using a highly calibrated, automated chemistry analyzer to photometrically or enzymatically measure total cholesterol, HDL cholesterol, and triglyceride concentrations.
  7. Result Reporting: Calculate the LDL cholesterol (if applicable and requested) and very-low-density lipoprotein (VLDL) based on the measured values. Compile the data and generate a final, verified laboratory report for transmission to the ordering provider's electronic health record system.

Coding Guidelines

  • Do not report CPT code 80061 unless all three constituent laboratory tests (Total Cholesterol [82465], HDL [83718], and Triglycerides [84478]) are successfully performed and resulted.
  • If only one or two of the required constituent tests are performed, you must report the individual CPT codes for those specific tests instead of utilizing the comprehensive panel code 80061.
  • Do not report CPT code 80061 in conjunction with CPT codes 82465, 83718, or 84478 for the same patient on the same date of service.
  • If a direct measurement of LDL cholesterol is explicitly ordered, medically necessary, and performed in addition to the lipid panel, report CPT code 83721 (Lipoprotein, direct measurement; LDL cholesterol) separately.
  • Calculated LDL cholesterol is considered an inherent component of the lipid panel interpretation and should not be billed separately using a direct measurement CPT code.
  • Diagnosis coding must clearly support the medical necessity of the panel, differentiating whether the test is performed for general screening (e.g., Z13.6) or for the monitoring of a known, established medical condition (e.g., E78.5).

Associated ICD-10 Codes